FDA GeneCorrect coverage for business development, investment, and market access teams
GeneTech's GeneCorrect has received FDA approval, marking a significant advancement in the treatment of cystic fibrosis and improving patient outcomes.
We use cookies to enhance your experience, analyze traffic, and for marketing. By continuing to use our site, you consent to our use of cookies. Privacy Policy
